Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Linperlisib in Combination with CHOP for Newly-Diagnosed Peripheral T-Cell Lymphoma: Preliminary Results from the Phase 1b/2 Linch Study

Qingqing Cai, Yi Xia, Huiqiang Huang, Ying Zhao, Fan Yang, Wenning Xu, Hongyan Tong, Chunmei Yang, Xiaojie Fang, Man Nie, Yu Fang, Gao Yan, Xuanye Zhang, Rong Tao, Xiuhua Sun, Xueyi Pan, Tao Wu, Yuchen Zhang, Jun Cai

Blood (2024) 144 (Supplement 1): 6407.

https://doi.org/10.1182/blood-2024-206564

Published: 2024

Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Blood (2024) 144 (Supplement 1): 4450.

https://doi.org/10.1182/blood-2024-209224

Published: 2024

Journal Articles

KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity

Wenzhuo Zhuang, Yuchen Zhang, Chunxiao Yang, Linlin Qin, Ruijing Hu, Menglu Chen, Xinyuan Zhang, Qi Li, Xingping Lang, Si Chen, Bingzong Li

Blood (2024) 144 (Supplement 1): 958.

https://doi.org/10.1182/blood-2024-198290

Published: 2024

Journal Articles

TQB2223 in Combination with Penpulimab in Patients with Relapsed or Refractory Lymphoma: Primary Analysis of an Open-Label Phase I Study

Qingqing Cai, Yi Xia, Xiaojie Fang, Man Nie, Qihua Zou, Jun Cai, Yuchen Zhang, Qiuyi Yang, Dawei Ding, Wen Wang, Xunqiang Wang

Blood (2024) 144 (Supplement 1): 3047.

https://doi.org/10.1182/blood-2024-203156

Published: 2024

Journal Articles

Multiplex Genome Editing of Human T Cells with Innovative Transformer Base Editor (tBE) for Construction of Next Generation CAR-T Therapies

Peixue Li, Qing Su, Ya Xu, Jing He, Lijie Wang, Yichuan Wang, Huanyu Li, Kewei Lan, Huiming Zheng, Di Zhu, Yan Zhang, Runni Guo, Hongxia Ma, Lang Zhang, Yuchen Zhang, Runze Gao, Bingbing Wu, Susan Mou, Jia Chen

Blood (2023) 142 (Supplement 1): 6825.

https://doi.org/10.1182/blood-2023-178504

Published: 2023

Journal Articles

Enhancing Therapeutic Efficacy: Harnessing the Synergy of Histone Deacetylase and BCL6 Inhibition in DLBCL

Wenzhuo Zhuang, Qi Li, Yuchen Zhang, Bingzong Li

Blood (2023) 142 (Supplement 1): 5800.

https://doi.org/10.1182/blood-2023-174616

Published: 2023

Journal Articles

Pharmacokinetic Characterization and Exposure-Response Relationship of Crovalimab in the COMPOSER and COMMODORE 3 Trials of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Simon Buatois, Khaled Benkali, Andrea Henrich, Félix Jaminion, Yuchen Zhang, Alexandre Sostelly

Blood (2022) 140 (Supplement 1): 2918–2920.

https://doi.org/10.1182/blood-2022-158244

Published: 2022

Journal Articles

Frontline Treatment with Zanubrutinib Plus Rituximab (ZR) Followed By Short Course R-Dhaox Shows Potent Efficacy in Patients with Mantle Cell Lymphoma (MCL) - Preliminary Results of Phase II CHESS Clinical Trial

Qingqing Cai, Yi Xia, Panpan Liu, Yuchen Zhang, Huiqiang Huang, Yan Gao, Guowei Li, Xiuhua Sun, Xueyi Pan

Blood (2022) 140 (Supplement 1): 9356–9357.

https://doi.org/10.1182/blood-2022-166237

Published: 2022

Journal Articles

Results from the First Phase 3 Crovalimab (C5 Inhibitor) Study (COMMODORE 3): Efficacy and Safety in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Hui Liu, Linghui Xia, Jianyu Weng, Fengkui Zhang, Chuan He, Sujun Gao, Jinsong Jia, Alice C. Chang, Pontus Lundberg, Camelia S. Sima, Jane Shi, Zhenyu Xiao, Yuchen Zhang, Zilu Zhang, Rong Fu

Blood (2022) 140 (Supplement 1): 714–716.

https://doi.org/10.1182/blood-2022-162452

Published: 2022

Journal Articles

Real-World Study Evaluating the Efficacy of Frontline Brentuximab Vedotin Plus Chemotherapy in Newly Diagnosed Patients with Hodgkin Lymphoma: A Retrospective Analysis

Qingqing Cai, Yi Xia, Panpan Liu, Yuchen Zhang, Qihua Zou, Jun Cai

Blood (2022) 140 (Supplement 1): 12035–12036.

https://doi.org/10.1182/blood-2022-156400

Published: 2022

Journal Articles

Central Nervous System Involvement in Extranodal Natural Killer/T-Cell Lymphoma: Case Series

Qingqing Cai, Jinni Wang, Yu Fang, Ning Su, Shuyun Ma, Jun Cai, Yuchen Zhang, Xiaopeng Tian, Huiqiang Huang, Zhiming Li, He Huang, Yi Xia, Panpan Liu

Blood (2021) 138 (Supplement 1): 1399.

https://doi.org/10.1182/blood-2021-150205

Published: 2021

Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-136842

Published: 2020

Journal Articles

The Bone Marrow-Derived Mesenchymal Cells Were Injured By Iron Overload through Catalyzing the Production of Reactive Oxidative Stress in Mice

Yuchen Zhang, MD, Mingfeng Zhao, MDPhD, Deguan Li, PhD, Xiaoli Cao, MD, Jie Chen, MD, Juan Mu, MD, Qing Li, MD, Xia Xiao, MD, Xiao Chai, MD, Aimin Meng, PhD

Blood (2014) 124 (21): 4373.

https://doi.org/10.1182/blood.V124.21.4373.4373

Published: 2014

Journal Articles

ROS-Mediated Iron Overload Injures The Hematopoiesis Of Bone Marrow By Damaging Hematopoietic Stem/Progenitor Cells In Mice

Xiao Chai, MD, Deguan Li, PhD, Mingfeng Zhao, MD&PhD, Wenyi Lu, MD, Juan Mu, MD, Xia Xiao, MD, Yuchen Zhang, MD, Qing Li, MD, Juanxia Meng, MD, Tao Sui, MD&PhD, Aimin Meng, PhD

Blood (2013) 122 (21): 962.

https://doi.org/10.1182/blood.V122.21.962.962

Published: 2013

NARROW

Linperlisib in Combination with CHOP for Newly-Diagnosed Peripheral T-Cell Lymphoma: Preliminary Results from the Phase 1b/2 Linch Study

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity

TQB2223 in Combination with Penpulimab in Patients with Relapsed or Refractory Lymphoma: Primary Analysis of an Open-Label Phase I Study

Multiplex Genome Editing of Human T Cells with Innovative Transformer Base Editor (tBE) for Construction of Next Generation CAR-T Therapies

Enhancing Therapeutic Efficacy: Harnessing the Synergy of Histone Deacetylase and BCL6 Inhibition in DLBCL

Pharmacokinetic Characterization and Exposure-Response Relationship of Crovalimab in the COMPOSER and COMMODORE 3 Trials of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Frontline Treatment with Zanubrutinib Plus Rituximab (ZR) Followed By Short Course R-Dhaox Shows Potent Efficacy in Patients with Mantle Cell Lymphoma (MCL) - Preliminary Results of Phase II CHESS Clinical Trial

Results from the First Phase 3 Crovalimab (C5 Inhibitor) Study (COMMODORE 3): Efficacy and Safety in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Real-World Study Evaluating the Efficacy of Frontline Brentuximab Vedotin Plus Chemotherapy in Newly Diagnosed Patients with Hodgkin Lymphoma: A Retrospective Analysis

Central Nervous System Involvement in Extranodal Natural Killer/T-Cell Lymphoma: Case Series

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

The Bone Marrow-Derived Mesenchymal Cells Were Injured By Iron Overload through Catalyzing the Production of Reactive Oxidative Stress in Mice

ROS-Mediated Iron Overload Injures The Hematopoiesis Of Bone Marrow By Damaging Hematopoietic Stem/Progenitor Cells In Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only